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Abstract 
Neurovascular dysfunction arising from endothelial cell damage is an early pathogenic event that contributes 
to the neurodegenerative process occurring in Alzheimer’s disease (AD). Since the mechanisms underlying 
endothelial dysfunction are not fully elucidated, this study was aimed to explore the hypothesis that brain 
endothelial cell death is induced upon the sustained activation of the endoplasmic reticulum (ER) stress 
response by amyloid-beta (Aβ) peptide, which deposits in the cerebral vessels in many AD patients and 
transgenic mice. Incubation of rat brain endothelial cells (RBE4 cell line) with Aβ1-40 increased the levels of 
several markers of ER stress-induced unfolded protein response (UPR), in a time-dependent manner, and 
affected the Ca2+ homeostasis due to the release of Ca2+ from this intracellular store. Finally, Aβ1-40 was 
shown to activate both mitochondria-dependent and -independent apoptotic cell death pathways. Enhanced 
release of cytochrome c from mitochondria and activation of the downstream caspase-9 were observed in 
cells treated with Aβ1-40 concomitantly with caspase-12 activation. Furthermore, Aβ1-40 activated the apoptosis 
effectors’ caspase-3 and promoted the translocation of apoptosis-inducing factor (AIF) to the nucleus 
demonstrating the involvement of caspase-dependent and -independent mechanisms during Aβ-induced 
endothelial cell death. In conclusion, our data demonstrate that ER stress plays a significant role in Aβ1-40-
induced apoptotic cell death in brain endothelial cells suggesting that ER stress-targeted therapeutic 
strategies might be useful in AD to counteract vascular defects and ultimately neurodegeneration. 
 
Keywords 
Alzheimer’s disease; amyloid-beta peptide; endothelial cells; endoplasmic reticulum stress; calcium 
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Abbreviations 
AD, Alzheimer’s disease; AIF, apoptosis-inducing factor; AM; acetoxymethyl ester; APP, amyloid precursor 
protein; ATF, activating transcription factor; Aβ, amyloid-beta; BBB, blood-brain barrier; bFGF, basic 
Fibroblast Growth Factor; CHOP, CAAT/enhancer binding protein homologous protein; DMSO, dimethyl 
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sulfoxide; ECF, Enhanced chemiFluorescence; ECs, endothelial cells; eIF2α; α subunit of eukaryotic 
translation initiation factor 2; ER, endoplasmic reticulum; GAPDH, glyceraldehyde-3-phosphate 
dehydrogenase; GRP78, glucose-regulated protein of 78 kDa; IRE1, inositol-requiring protein-1; JNK, c-jun 
N-terminal kinase; LDH, lactate dehydrogenase; LRP, low-density lipoprotein receptor-related protein; MTT, 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NAD+, oxidized nicotinamide adenine 
dinucleotide; NADH, nicotinamide adenine dinucleotide; PARP1, poly(ADP-ribose) polymerase 1; PERK; 
protein kinase RNA-like ER kinase; PI, propidium iodide; PS, presenilinM; PVDF, Polyvinylidene difluoride; 
RAGE, receptor for advanced glycation end products; RBE4, rat brain endothelial cell line; RT, room 
temperature; Ry, ryanodine; RyR, ryanodine receptor; SDS-PAGE, SDS-polyacrylamide gel; SERCA, 
sarco/ER Ca2+ ATPase; TBP, TATA-binding protein; TBS-T, TBS-Tween; ThS, thioflavine S; TUNEL, 
terminal deoxynucleotidyl transferase dUTP nick-end labeling; UPR, unfolded protein response; WB, Western 
blot; XBP-1, X-box binding protein-1; mit, mitochondrial membrane potential. 
 
1. Introduction 
According to the ‘Amyloid Cascade Hypothesis’, the accumulation of amyloid-beta (Aβ) in brain parenchyma 
is responsible for the neurodegenerative process in Alzheimer’s disease (AD) [1]. Furthermore, numerous 
studies support that neurovascular dysfunction contributes to neurodegeneration and cognitive decline and 
thus have a major role in AD pathogenesis (reviewed in [2]). First, vascular risk factors such as diabetes, 
obesity, hypercholesterolemia, hypertension, atherosclerosis, and stroke significantly increase the risk to 
develop AD [3, 4]. Second, combined evidences from neuroimaging and neuropathological studies show that 
signs of vascular pathology develop early in AD and occur before the disease becomes symptomatic [5, 6]. 
Third, deficient clearance of Aβ across the blood-brain barrier (BBB) has been described in the brain of AD 
patients [2]. Finally, Aβ deposition was found in the cerebral microvasculature of AD transgenic mice and in 
cerebrovessels in many AD patients  and contributes to the age-dependent degeneration of cerebral 
vasculature and development of cerebral amyloid angiopathy, characterized by dysfunction of brain capillary 
endothelium [7, 8]. This dysfunction correlates with the toxic effects of Aβ on endothelial cells (ECs) and has 
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been extensively described in cultured cells, in isolated vessels as well as in whole animals [9-12]. Aβ 
induces irreversible morphological and functional changes of ECs resulting in suppression of their 
proliferative activity and reduced survival [13, 14]. In addition, Aβ-induced apoptosis was demonstrated in 
cultured cerebral ECs [9], but the underlying mechanisms have not been fully elucidated. It was reported that 
endoplasmic reticulum (ER) stress is a stimulus that initiates apoptotic cell death pathways in vascular ECs 
[15, 16], but its role in Aβ-induced endothelial dysfunction has not been addressed yet. 
The ER is the principal organelle responsible for proper folding/processing of nascent proteins and Ca2+ 
homeostasis. Perturbed ER function leads to a state known as ER stress. To ameliorate this stress, 
mammalian cells possess a homeostatic set of protein signalling pathways and transcription factors termed 
the unfolded protein response (UPR). The UPR utilizes three types of ER-resident sensor proteins, inositol-
requiring protein-1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor 6 
(ATF6), that are activated after the ER-resident chaperone glucose-regulated protein of 78kDa (GRP78, also 
known by immunoglobulin binding protein, BiP) dissociates from their ER luminal domains and initiate ER-to-
nucleus signalling cascades to maintain the homeostasis [17, 18]. However, persistent and severe ER stress 
triggers apoptotic cascades resulting in cell death [19]. Upon dimerization and autophosphorylation, PERK 
inactivates the α subunit of eukaryotic translation initiation factor 2 (eIF2α) by phosphorylation at Ser51, 
required for 80S ribosome assembly, thus inhibiting general protein translation through a decrease in the 
GTP-bound form of eIF2α, but increasing the translation of the transcription factor ATF4. In the nucleus, 
ATF4 induces the transcription of several genes involved in controlling the UPR and growth arrest and DNA 
damage-inducible protein-34 (GADD34). GADD34 induces a negative feedback and dephosphorylates eIF2α 
[20, 21]. IRE1α removes a 26-base intron of mRNA of X-box binding protein-1 (XBP-1) inducing a more 
efficient translation and a more stable protein. The resulting XBP-1 protein with 54 kDa instead of 33 kDa 
comprises the original N-terminal DNA binding domain and a transactivation domain in the C-terminal and is 
a transcription factor that regulates genes involved in the ER-associated degradation pathway and increases 
the expression of several ER resident chaperones, such as GRP78 [22]. Upon dissociation from GRP78, 
ATF6 migrates to the Golgi apparatus where it is cleaved to release a transcription factor that upregulates 
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genes involved in amplification of folding capacity such as chaperones including GRP78 and also genes for 
protein disulfide isomerases, CAAT/enhancer binding protein homologous protein (CHOP, also termed 
GADD153), XBP-1 [21, 23], and genes involved in angiogenesis and autophagy [20]. During prolonged ER 
stress, apoptotic cell death is induced by the c-jun N-terminal kinase (JNK) pathway, by caspases, including 
the ER membrane-associated caspase-12 (in murine or the homologue caspase-4 in humans) or 
upregulation of the transcription of CHOP [19, 24]. CHOP functions to block cells transition from G1 to S 
phase during cell cycle progression and can directly activate GADD34 increasing oxidation reactions at the 
ER [25]. Furthermore, CHOP down-regulates Bcl-2 and induces the translocation of Bax to mitochondria and 
subsequent cytochrome c release and activation of the apoptosis-effector caspase-3 [26]. Besides, ER and 
mitochondria are physically close and in contact and communicate through Ca2+ signals [27]. In normal 
conditions, Ca2+ released from ER is taken up by mitochondria and increases ATP production. Nevertheless, 
an overload in Ca2+ uptake by mitochondria upon ER Ca2+ release promoted by apoptotic stimuli or ER stress 
could induce the release of cytochrome c and other caspase cofactors leading to apoptotic cell death [27]. In 
neurons, the mitochondrial uptake of Ca2+ released form ER is essential to activate the mitochondrial 
apoptotic cell death pathway under Aβ1-40-induced ER stress conditions [28]. 
Reports are available describing the engagement of ER stress in AD. In brain post-mortem samples from 
early AD patients, but not in non-demented subjects, ER stress markers have been detected in the temporal 
cortex and hippocampus [29]. Moreover, in transgenic mice modelling AD, increased brain levels of several 
ER stress markers have been described [30, 31]. The presenilins (PSs, components of the γ-secretase 
complex present in the ER membrane) function as low-conductance, passive ER Ca2+ leak channels and, 
consequently, familial AD-linked PSs mutations disturb ER Ca2+ homeostasis leading to increased 
susceptibility to activation of UPR and caspase-4-induced apoptosis [19, 32, 33]. Nonetheless, mutant PS1 
reduces global ER function since it suppresses the activation of IRE1α, ATF6, and PERK and, as a result, 
GRP78/BiP is downregulated in PS1 mutant AD patients [19]. GRP78/BiP is able to bind the amyloid 
precursor protein (APP) inhibiting Aβ generation [34, 35]. Therefore, mutant PS1 may increase the 
generation of Aβ by reducing the levels of GRP78/BiP available to bind APP. Moreover, aberrant splicing of 
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PS2, almost exclusively observed in the brains of sporadic AD patients, increases the production of Aβ and 
the vulnerability to ER stress [36] and, may thus be implicated in the pathogenesis of this form of the disease.  
Our previous in vitro results highlighted the role of ER stress in neuronal dysfunction triggered by Aβ [37, 38] 
but the impact of ER stress in Aβ-induced endothelial dysfunction has not been investigated yet. Therefore, 
the aim of this work was to analyze the molecular basis of cerebrovascular alterations in AD exploring the 
hypothesis that Aβ1-40, which preferentially accumulates in brain vasculature [8, 39], damages microvascular 
brain ECs through induction of ER stress-mediated cell death pathways.  
 
2. Experimental procedures 
2.1. Materials 
Indo-1 acetoxymethyl ester (Indo-1/AM), Alexa Fluor 488 goat anti-rabbit IgG conjugate, Fura-2 
acetoxymethyl ester (Fura-2/AM), Tetramethylrhodamine methyl ester (TMRM), and Hoechst 33342 were 
obtained from Molecular Probes (Leiden, The Netherlands). The synthetic Aβ1−40 peptide was from Bachem 
(Bubendorf, Switzerland). Ionomycin, ProteoExtract® Subcellular Proteome Extraction Kit, and colorimetric 
substrates for caspase-3, -9 and -12 (Ac-DEVD-pNA, Ac-LEHD-pNA, and Ac-LEVD-pNA, respectively) were 
purchased from Calbiochem (Darmstadt, Germany). Polyvinylidene difluoride (PVDF) membrane, goat 
alkaline phosphatase-linked anti-rabbit and anti-mouse secondary antibodies, and the Enhanced 
chemiFluorescence (ECF) reagent were acquired from Amersham Pharmacia Biotech (Buckinghamshire, 
UK). Mouse monoclonal antibody against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was from 
Chemicon International Inc. (Temecula, CA, USA). The Glycergel Mounting Medium was purchased from 
DakoCytomation Inc. (Carpinteria, CA, USA). Bio-Rad protein dye assay reagent, acrylamide, and the 
prestained Precision Plus Protein All Blue Standard were purchased from Bio-Rad (Hercules, CA, USA). The 
In Situ Cell Death Detection Kit, Fluorescein (with terminal deoxynucleotidyl transferase dUTP nick-end 
labeling, TUNEL), and collagen were obtained from Roche Applied Science (Mannheim, Germany). Trypsin 
EDTA solution, thioflavin S (ThS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), anti-α-
tubulin mouse monoclonal antibody, protease inhibitors (leupeptin, pepstatin A, chymostatin, and aprotinin), 
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thapsigargin, recombinant human basic Fibroblast Growth Factor (bFGF), oligomycin, carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP), dantrolene sodium, and mouse monoclonal antibody reactive 
against ATF4 were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Rabbit polyclonal antibodies 
reactive against XBP1 and mouse monoclonal antibody reactive against TATA-binding protein (TBP) were 
acquired from Abcam plc (Cambridge, UK). Mouse monoclonal antibodies reactive against GRP78 and 
cytochrome c, and rabbit polyclonal antibody reactive against caspase-12 were from BD Biosciences 
(Heiderlberg, Germany). Mouse monoclonal antibodies reactive against CHOP/GADD153 or apoptosis-
inducing factor (AIF), and rabbit polyclonal antibodies reactive against ATF6α or Tom20 were obtained from 
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Rabbit polyclonal antibodies reactive against Bax or 
cleaved poly(ADP-ribose) polymerase 1 (PARP1) (Asp214), and rabbit monoclonal antibody against Bcl-2 
were acquired from Cell Signaling Technology, Inc. (Danvers, MA, USA). Mem-Alpha medium with Glutamax-
1, Nut Mix F-10 W/GLUTAMAX-1, and geneticin were acquired from Invitrogen Life Science (Paisley, UK). 
 
2.2. Culture of rat brain endothelial cell line RBE4 and treatments 
The rat brain endothelial cell line RBE4 was provided by Dr. Jon Holy (University of Minnesota, Duluth, USA). 
RBE4 is a continuous, immortalized cell line that retains a stable phenotype reminiscent of BBB endothelium 
in vitro [40]. Cells at passages 10-35 were grown on 75 cm2 tissue culture flasks coated with 4.15 μg/cm2 
collagen in MEM-Alpha medium with Glutamax-1 and Nut Mix F-10 W/GLUTAMAX-1 (1:1 vol/vol), 
supplemented with 1 ng/ml bFGF and 0.3 mg/ml geneticin. Cells were maintained at 37ºC in a humidified 
atmosphere of 5% CO2/95% air. 
RBE4 cells were plated on collagen-coated (4.15 μg/cm2) multiwell plates at a density of approximately 
22,000 cells/cm2 and were then treated with 0.1 or 2.5 μM Aβ1-40 during 3-24 hr. Thereafter, cell viability, 
protein levels of ER stress markers as well as of apoptosis, levels of cytosolic Ca2+, mitochondrial membrane 
potential (mit), and also caspases-3, -9 and -12-like activities were measured. Alternatively, RBE4 cells 
plated in coverslips coated with poly-L-lysine (0.1 mg/ml) and then collagen (4.15 μg/cm2) were treated with 
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2.5 M Aβ1-40 for 3, 6, 12 or 24 hr and after that fibrillar content, ATF6 nuclear localization, necrotic/apoptotic 
cell death markers, and ER Ca2+ content were analyzed.  
Synthetic Aβ1-40-HCl was dissolved in sterile water at a concentration of 6 mg/ml and then diluted to 1 mg/ml 
(231 μM) in PBS and stored at -20ºC until use. 
 
2.3. Detection of Aβ fibrils in cell culture 
The presence of β-sheet fibrils has been assessed by ThS staining in RBE4 cells treated with 2.5 μM “fresh” 
Aβ1-40 during 3 hr. In brief, control and treated cells were washed with PBS buffer (pH 7.4) and were fixed 
with 4% paraformaldehyde for 15 min at RT. The cells were permeabilized with 0.2% Triton X-100 in PBS 
buffer (pH 7.4), for 2 min, at RT and were then incubated with a 1% ThS solution for 20 min in the dark. Cells 
were subsequently washed with PBS buffer (pH 7.4), with a 70% ethanol solution (quick wash) and finally 
with PBS. Then, coverslips mounted in DakoCytomation Fluorescent mounting solution on a microscope slide 
for the visualization in a fluorescence microscope (Zeiss axioskop2, Zeiss, Jena, Germany).  
 
2.4. Analysis of cell viability by the MTT assay 
Cell viability was evaluated using the MTT assay, which measures the ability of metabolic active cells to form 
formazan through cleavage of the tetrazolium ring of MTT [41]. Briefly, cells were washed in normal sodium 
medium (in mM: 132 NaCl, 4 KCl, 1.2 Na2HPO4, 1.4 MgCl2, 6 glucose, 10 HEPES, and 1 CaCl2, pH 7.4) and 
incubated with 0.5 mg/ml MTT for 2 hr at 37ºC. The blue formazan crystals formed were dissolved in an 
equal volume of 0.04 M HCl in isopropanol and quantified spectrophotometrically by measuring the 
absorbance at 570 nm using a microplater reader (SpectraMax Plus 384, Molecular Devices, California, 
USA). Results were expressed as the percentage of the absorbance determined in control cells. 
 
2.5. Analysis of plasma membrane integrity by the lactate dehydrogenase (LDH) assay 
The integrity of the plasma membrane was evaluated by determining the release of the cytoplasmic enzyme 
LDH as previously described [42]. The activity of intracellular and released LDH was determined 
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spectrophotometrically (Pharma Spec, UV-1700, UV-Visible spectrophotometer, Shimadzu), by following the 
rate of conversion of reduced nicotinamide adenine dinucleotide (NADH) to oxidized nicotinamide adenine 
dinucleotide (NAD+) at 340 nm. After cell treatment, the medium was collected (extracellular LDH) and the 
cells were lysed in 10 mM HEPES (pH 7.4) plus 0.01% (v/v) Triton X-100 (intracellular LDH) followed by 3 
cycles of freezing (-80°C) and thawing. In both intra and extracellular aliquots, cell debris were removed by 
centrifugation at 20,800 g for 10 min. LDH release into the extracellular medium was calculated as the 
percentage of total LDH activity (extracellular + intracellular LDH), and then expressed relatively to the 
control. 
 
2.6. Quantification of apoptotic and necrotic cells by the TUNEL assay and using Hoechst 
33342/propidium iodide staining 
Apoptotic cell death was analyzed by the TUNEL assay [28], performed using an In Situ Cell Death Detection 
Kit, according to the manufacturer’s directions. ECs cultured on glass coverslips were washed in PBS buffer 
(pH 7.4) and fixed with 4% (w/v) paraformaldehyde for 30 min at room temperature (RT). Then, slides were 
rinsed twice in PBS buffer and immersed in 0.1% (v/v) Triton X-100 supplemented with 0.1% (w/v) sodium 
citrate in iced PBS, for 2 min, to permeabilize the cells. Coverslips were rinsed again 3 times with PBS and 
incubated with TUNEL mixture for 1 hr at 37ºC, in the dark. Finally, coverslips were rinsed 3 times with PBS 
and mounted with Glycergel Mounting Medium onto a microscope slide for visualization in a fluorescence 
microscope (Zeiss axioskop2, Zeiss, Jena, Germany) with a 40x objective. DNAse-treated cells were used as 
a positive control.  
The number of apoptotic and necrotic cells was analyzed by nuclear morphology criteria using Hoechst 
33342 (which is able to cross cell membranes and binds chromatin) and propidium iodide (PI, which only 
cross damaged membranes and binds chromatin) staining in live cells. After treatment in coverslips, ECs 
were washed two times with PBS at 37ºC, incubated with 15 μg/ml Hoechst 33342 and 3 μg/ml PI in PBS for 
5 min in the dark, washed again two times with PBS and mounted with PBS at 37ºC on a microscope slide 
and observed in a fluorescence microscope (Zeiss axioskop2, Zeiss, Jena, Germany) using a 40x objective. 
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Viable cells display a normal nuclear size without PI staining. The cells with normal nuclear size with PI 
staining were scored as necrotic cells. Scored apoptotic ECs include cells that display pyknotic nuclei with 
condensed or fragmented chromatin with or without PI staining (primary and secondary apoptotic cells). All 
experiments were performed three times in duplicate, and a minimum of 150 cells were scored for each 
coverslip. The number of apoptotic and necrotic cells were expressed as the percentage (%) of the total 
number of cells in all microscope fields for each coverslip. 
 
2.7. Western blot analysis of ER stress and apoptotic markers 
Proteins levels of ER stress markers were evaluated by immunoblotting using cellular extracts obtained from 
treated or untreated ECs. First, cells were washed 2 times with PBS (pH 7.4) and scraped in ice cold lysis 
buffer (in mM): 25 HEPES-Na, 2 MgCl2, 1 EDTA, 1 EGT , supplemented with 0.1 mM PMSF, 2 mM DTT, 
and 1:1000 of a protease inhibitor cocktail (1 μg/ml leupeptin, pepstatin A, chymostatin, and antipain). The 
cellular extracts were then rapidly frozen in liquid N2 and thawed, centrifuged for 1 min at 106 g at 4ºC and 
the supernatant was collected. Apoptotic markers protein levels were also evaluated by immunoblotting using 
cytosolic, nuclear or mitochondrial fractions from treated or untreated ECs obtained with the ProteoExtract® 
Subcellular Proteome Extraction Kit according to the manufacture’s instruction. The protein content was 
measured using the Bio-Rad protein dye assay reagent. 
Total cellular extracts containing 15 µg protein, or cytosolic, nuclear and mitochondrial fractions containing 30 
µg protein, were separated by electrophoresis on 10% (w/v) SDS-polyacrylamide gel (SDS-PAGE) after 
denaturation at 95ºC for 5 min in sample buffer (in mM): 100 Tris, 100 DTT, 4% (v/v) SDS, 0.2% (w/v) 
bromophenol blue and 20% (v/v) glycerol. To facilitate the identification of proteins of interest, the prestained 
Precision Plus Protein All Blue Standards was used. Proteins were then transferred to PVDF membranes, 
which were further blocked for 1 hr at RT with 5% (w/v) BSA in Tris-buffered saline (150 mM NaCl, 50 mM 
Tris, pH 7.6) with 0.1% (w/v) Tween 20 (TBS-T). The membranes were next incubated overnight at 4ºC with 
a primary mouse monoclonal antibody against GRP78 (1:1,000 dilution in TBS-T), CHOP/GADD153 (1:500 
dilution in TBS-T), ATF4 (1:250 dilution in TBS-T), cytochrome c (1:500 dilution in TBS-T) or AIF (1:1000 
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dilution in TBS-T) or with a primary rabbit antibody against pro-caspase-12 (1:1,000 dilution  in TBS-T), 
ATF6α (1:1,000 dilution  in TBS-T), XBP1 (1:1,000 dilution in TBS-T), Bcl-2 (1:1,000 dilution  in TBS-T) or 
Bax (1:1,000 dilution in TBS-T). Control of protein loading was performed using a primary mouse against 
GAPDH antibody (1:1,000 dilution in TBS-T) or a primary mouse anti-α-tubulin antibody (1:20,000 dilution in 
TBS-T) for total cellular or cytosolic extracts , a primary rabbit anti-Tom20 antibody (1:500 dilution in TBS-T) 
for mitochondrial extracts, and a primary mouse against TBP antibody (1:2,000 dilution in TBS-T) for nuclear 
extracts. After washing, membranes were incubated for 1 hr at RT with an alkaline phosphatase conjugated 
secondary anti-mouse or anti-rabbit antibody (1:20,000 dilution in TBS-T). Bands of immunoreactive proteins 
were visualized after membrane incubation with ECF reagent during approximately 5 min, on a Versa Doc 
3000 Imaging System (Bio-Rad, Hercules, CA, USA) and densities of protein bands were calculated using 
the WCIF ImageJ program (Wayne Rasband, Research Services Branch, National Institute of Mental Health, 
Bethesda, Maryland, USA). The ratios between pro-caspase-12, caspase-12, or AIF and GAPDH, the ratios 
between GRP78, ATF6α, GADD153, XBP1, or ATF4 and α-tubulin, the ratios cytochrome c in 
mitochondria/total (cytochrome c in mitochondria plus cytochrome c in the cytosol), or cytochrome c in the 
cytosol/total and the ratios Bax/Bcl-2 in mitochondria or Bax/Bcl-2 in the cytosol were calculated and results 
were normalized to control values. 
 
2.8. Evaluation of ATF6 activation or PARP1 cleavage by immunocytochemistry 
In order to analyze the translocation of ATF6 to the nucleus or the cleavage of PARP1 by caspases, treated 
or untreated ECs grown in glass coverslips were rinsed two times with PBS (pH 7.4) and then fixed with 4% 
(w/v) paraformaldehyde at RT for 30 min. Cells were then washed two times with PBS. Coverslip-plated ECs 
were permeabilized with 0.2% (v/v) Triton X-100 for 2 min and were then incubated for 30 min at RT in 
blocking solution containing 3% (w/v) BSA in PBS to prevent non-specific binding. Subsequently, cells were 
incubated during 1 hr at 4°C with a primary rabbit anti-ATF6 antibody or against the large fragment resulting 
from caspases cleavage of rat PARP1 (1:200 dilution in blocking solution). Thereafter, coverslips were rinsed 
in PBS and incubated for 1 hr at RT with the secondary antibody anti-rabbit IgG labelled with Alexa Fluor 488 
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(1:200 dilution) diluted in PBS with 1% (w/v) BSA. Following additional rinses in PBS, cells were stained in 
the dark for 5 min, at RT, with 15 μg/ml Hoechst 33342 prepared in PBS. Finally, the preparations were 
mounted using Glycergel Mounting Medium. Images were collected using a Zeiss LSM 510 Meta confocal 
microscope (Carl Zeiss, New York, USA) with a 63x objective or in a fluorescence microscope (Zeiss 
axioskop2, Zeiss, Jena, Germany) with a 40x objective. All experiments were performed three times in 
duplicate, and a minimum of 100 cells were scored for each coverslip. For ATF6α nuclear translocation 
analysis, the fluorescence and the area of cell nucleus were quantified using the WCIF ImageJ program 
(Wayne Rasband, Research Services Branch, National Institute of Mental Health, Bethesda, Maryland, USA) 
and the ratio fluorescence/area calculated. 
 
2.9. Analysis of ER calcium content by single cell imaging with Fura-2/AM 
The content of Ca2+ in the ER was measured by single cell Ca2+ imaging using the fluorescent probe Fura-
2/AM, according to the method described by Ferreiro and colleagues [28]. Treated and untreated cells, plated 
in glass coverslips, were washed 2 times in sodium medium without Na2HPO4 (in mM: 132 NaCl, 4 KCl, 1 
CaCl2, 1.4 MgCl2, 6 glucose, 10 HEPES-Na, pH 7.4) and supplemented with 10 mM NaHCO3, 0.05 mM 
EGTA, and 0.1% (w/v) fatty acid-free BSA, pH 7.4. Then, cells were loaded with 5 μM Fura-2/AM in the same 
medium supplemented with 0.2% (w/v) pluronic acid for 40 min, at 37°C in the dark. Afterwards, cells were 
washed 3 times in Ca2+-free Krebs medium and the coverslips were assembled to perfusion chamber, in the 
same Ca2+-free medium, in an inverted fluorescence microscope (Axiovert 200, Zeiss, Jena, Germany). Cells 
were alternatively excited at 340 and 380 nm using a Lambda DG4 apparatus (Sutter Instruments Company, 
Novaco, CA, USA), and emitted fluorescence at 510 nm was collected with a 40x objective and was driven to 
a coll SNAP digital camera (Roper Scientific, Trenton, NJ, USA). After a baseline was established, cells were 
stimulated with thapsigargin (2.5 μM), to empty ER Ca2+ stores. Acquired values were processed using the 
MetaFluor software (Universal Imaging Corporation, Buckinghamshire, UK). The increase in 340/380 nm ratio 
is proportional to ER Ca2+ content and the absence of external Ca2+ guarantees that the increase in the Fura-
2 fluorescence ratio is due solely to the release of Ca2+ from the ER. The peak amplitude of Fura-2 
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fluorescence (ratio at 340/380 nm) was used to evaluate ER Ca2+ content that was normalized to control 
values.  
 
2.10. Measurement of cytosolic calcium concentration with Indo-1/AM 
The cytosolic Ca2+ concentration was measured in RBE4 cells cultured on 24-well plates. Cells were 
incubated in the dark with 3 µM Indo-1/AM in sodium medium without Na2HPO4 for 45 min at 37ºC, and were 
further incubated for 15 min in the absence of Indo-1/AM to ensure a complete hydrolysis of the 
acetoxymethyl ester. Subsequently, Indo-1 fluorescence was measured in a microplate reader (SpectraMax 
Gemini EM fluorocytometer, Molecular Devices, California, USA) with excitation at 350 nm and emission at 
410 nm. The free cytosolic Ca2+ concentration was calculated using the Fmax and AF (Autofluorescence) 
values determined after the addition of ionomycin (3 µM) and MnCl2 (3 mM), respectively [43] and the results 
were expressed relatively to the control. 
 
2.11. Mitochondrial membrane potential measurements 
The mit was measured using the fluorescent dye TMRM. This cationic indicator is accumulated 
preferentially into energized mitochondria driven by the membrane potential. In the final of the treatments, 
RBE4 cells were washed with PBS and incubated with 300 nM TMRM in sodium medium for 1hr at 37ºC in 
the dark. Then, the medium was replaced by sodium medium at 37ºC and the fluorescence was measured in 
a microplate reader (SpectraMax Gemini EM fluorocytometer, Molecular Devices, California, USA) with 
excitation at 540 nm and emission at 590 nm (F). 1M FCCP and 2 g/ml oligomycin were added and the 
fluorescence measured again (F0). The differences between F and F0 were calculated and the results were 
expressed relatively to untreated cells. 
 
2.12. Analysis of caspase-3,- 9-, and -12-like activity 
The activation of caspases-3, -9, and -12 was investigated in extracts from control and treated RBE4 cells. 
After treatments, ECs were washed two times with PBS at 4ºC and scraped in reaction buffer: 25 mM 
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HEPES-Na, 10% (w/v) sucrose, 10 mM DTT, and 0.1% (w/v) CHAPS (pH 7.4). The cellular extract was 
rapidly frozen and thawed three times in liquid N2, and then centrifuged for 10 min at 20,800 g at 4ºC. The 
supernatant was collected and assayed for protein content using the Bio-Rad protein dye assay reagent. 
Aliquots of cellular extracts containing 30 μg of protein were reacted with 0.1 mM Ac-DEVD-pNA 
(chromogenic substrate for caspase-3), Ac-LEHD-pNA (chromogenic substrate for caspase-9) or Ac-LEVD-
pNA (chromogenic substrate for caspase-12), in reaction buffer for 2 hr at 37ºC. Caspase-3, -9, and -12-like 
activity was determined by measuring substrate cleavage at 405 nm in a microplate reader (SpectraMax Plus 
384) and results were expressed relatively to the control. 
 
2.13. Data analysis 
Data were expressed as means ± SEM of measurements performed in duplicate, from at least three 
independent experiments. Statistical significance analysis was determined using one-way ANOVA followed 
by Dunnett’s post hoc tests or using Student’s t-test in the GraphPad Prism Software (San Diego, CA, USA). 
The differences were considered significant for P values < 0.05. 
 
3. Results 
3.1. Aβ1-40 peptide decreases brain endothelial cell survival and activates apoptotic cell death 
Previously, we have shown that the addition of Aβ40-1 to cell culture medium do not significantly affect cell’s 
morphology and survival [37, 44], demonstrating the specificity of the amino acids sequence of Aβ1-40. Here, 
incubation of RBE4 cells for 3-24 hr with 0.1 or 2.5 μM Aβ1-40, which forms small aggregates in culture (Fig. 
1A), decreased cell survival, as evaluated by the MTT assay, in a dose- and time-dependent manner (Fig. 
1B). A statistical significant decrease in the ability to reduce MTT, and thus in cell viability, was observed 
when RBE4 cells were exposed to 0.1 μM Aβ1-40 for 12 or 24 hr or to 2.5 μM Aβ1-40 for 3 or more hours. 
Accordingly with these results, the Aβ1-40 concentration of 2.5 μM was used in subsequent studies. Aβ1-40 was 
shown to preserve the integrity of the plasma membrane since no significant release of LDH occurred after 6 
or 24 hr (Fig. 1C), suggesting that necrosis doesn’t contribute to Aβ-induced cell death in brain ECs. These 
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results were corroborated with Hoechst 33342/PI showing that the number of necrotic cells was not affected 
by Aβ1-40 treatment (Fig. 1D and E). Moreover, in RBE4 cells treated with 2.5 μM Aβ1-40 during 24 hr, a 
significant increase in the number of apoptotic cells, as determined using Hoechst 33342/PI staining (Fig. 1D 
and E) and the TUNEL assay (Fig. 1F and G). Taken together, these results show that Aβ1-40 is toxic to brain 
ECs compromising cell survival and leading to the activation of an apoptotic cell death pathway.  
 
3.2. Aβ1-40 induces ER stress in brain endothelial cells 
The levels of several ER stress markers were determined in Aβ1-40-treated brain ECs by Western Blot (WB). 
Significant increases in proteins levels of ATF4 (Fig. 2A and B) (activated downstream of the PERK ER 
stress sensor), unspliced XBP1 (Fig. 2A and C) (the transcription of XBP-1 gene increases upon UPR 
activation), spliced XBP1 (Fig. 2A and D) (downstream of the IRE1 ER stress sensor), active ATF6α (Fig. 
2A and E) (the 55 kDa fragment that results from ATF6α cleavage within the Golgi apparatus), and the ER 
chaperone GRP78/BiP (Fig. 2A and F) were observed in RBE4 cells treated with Aβ1-40 for 3, 6, or 12 hr, but 
not 24 hr. The subcellular localization of ATF6α was also followed by immunocytochemistry and a significant 
increase in ATF6α staining was observed in cells treated with Aβ1-40 for 6 hr, especially in the nucleus, 
comparatively to that detected in control cells in the absence of Aβ1-40 treatment (Fig. 2G and H) supporting 
the nuclear translocation of cleaved ATF6α under these conditions. These results demonstrate that ER stress 
is activated in ECs exposed to toxic Aβ1-40 concentrations. 
 
3.3. ER and cytosolic calcium homeostasis is impaired by Aβ1-40 in brain endothelial cells 
The levels of Ca2+ in the ER and in the cytosol were analyzed in ECs treated with 2.5 M Aβ1-40 for 3 or 24 hr 
and for 3, 6, 12, or 24 hr, respectively. Under these conditions, the ER Ca2+ content was shown to be 
significantly depleted in RBE4 cells after Aβ1-40 treatment, as analyzed by single cell Ca
2+ imaging with Fura-
2/AM (Fig. 3A and B). Moreover, a significant rise in cytosolic Ca2+ levels measured with Indo-1/AM was 
observed in Aβ1-40-treated cells (Fig. 3C). These results suggest that Aβ1-40 impairs ER Ca
2+ homeostasis 
leading to the early release of Ca2+ from ER subsequently increasing cytosolic Ca2+ levels. Changes in ER 
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Ca2+ content are correlated with activation of ER stress sensors (Fig. 2). In addition, impairment of Ca2+ 
homeostasis precedes activation of apoptotic cell death (Fig. 1D-G).  
 
3.4. Activation of the ER stress-mediated apoptotic pathway in Aβ1-40-treated brain endothelial cells 
The levels of CHOP/GADD153, a pro-apoptotic transcription factor that is activated under ER stress 
conditions, were shown to be affected in RBE4 cells by Aβ1-40 in a time-dependent manner with a maximal 
increase observed at 3 and 6 hr of treatment (Fig. 4). Cytochrome c, Bax and Bcl-2 protein levels were also 
analyzed in cytosolic and mitochondrial sub-cellular fractions by WB and mit after 3, 6, 12, or 24 hr of 
incubation with Aβ1-40 (Fig. 5). The ratio between Bax and Bcl-2 protein levels in mitochondria was 
significantly augmented with a maximal increase at 12 hr of treatment with Aβ1-40 (Fig. 5B). Concomitantly, 
this ratio decreased in the cytosol but statistical significance was only observed at 3 hr (Fig. 5C). Cytochrome 
c levels were significantly decreased in mitochondria (Fig. 5D) and increased in cytosol (Fig. 5E) with a 
maximum release from mitochondria determined after 12 hr of treatment with Aβ1-40. In addition, mit 
decreased upon Aβ1-40 treatment with a minimum at 12 hr (Fig.5F) that was reverted by dantrolene (Fig. 5G). 
These results suggest that activation of CHOP/GADD153 under Aβ1-40-induced ER stress conditions 
promotes the translocation of Bax from the cytosol to the mitochondria, decreasing mit and leading to 
cytochrome c release.  
The activation of the ER resident caspase-12 was by WB. After exposure of RBE4 cells to Aβ1-40 during 3, 6, 
12 or 24 hr, the levels of pro-caspase-12 were not significantly altered (Fig. 6A and B) but the levels of the 
active form caspase-12 increased until 12 hr of Aβ1-40 treatment returning to control values at 24 hr (Fig.6A 
and C). Furthermore, caspase-12-like activity was shown to be increased in Aβ1-40-treated cells after 6 and 12 
hr incubation, but not at 24 hr (Fig. 6D). Similarly, a significant increase in caspase-like activities of caspase-9 
(Fig. 6E) and caspase-3 (Fig. 6F) was determined 6 and 12 hr after Aβ1-40 exposure, but not at 24 hr. The 
cleavage of PARP1 by caspases, namely caspase-3, after incubation of RBE4 cells with 2.5 μM Aβ1-40 during 
12 or 24 hr was evaluated by immunocytochemistry using a specific antibody, which recognizes the large 
fragment with 89 kDa of PARP1 resulting from caspase cleavage at Asp214, and Hoechst 33342 to label 
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nuclei . An increase in cleaved PARP1 was observed in Aβ1-40-treated cells both after 12 and 24 hr incubation 
(Fig. 6G). Together, these results demonstrate that Aβ-induced ER stress leads to apoptotic cell death in ECs 
through mitochondria-independent pathways, mediated by caspase-12 activation, but also through 
mitochondria-dependent pathways that rely on the release of mitochondrial cytochrome c upon Bax 
translocation to mitochondria and subsequent activation of caspases-9 and -3 finally leading to cleavage of 
apoptosis substrates and cell death.  
 
3.5. Aβ1-40-treatment induces the translocation of AIF to the nucleus 
The release of AIF from mitochondria and subsequent translocation to the nucleus was evaluated by WB in 
mitochondrial and nuclear extracts obtained from control and Aβ1-40-treated RBE4 cells for 3 to 24 hr. The 
content of AIF in the cytosol was very low (Fig. 7A) suggesting that AIF released from mitochondria was 
rapidly degraded or translocated to the nucleus. After 24 hr of Aβ1-40 treatment, a slight decrease in 
mitochondrial AIF content (Fig. 7A and B) and a significant increase in AIF levels in the nucleus (Fig. 7A and 
C) were observed. These findings support that Aβ1-40-induced Bax translocation to the mitochondria also 
activates AIF-mediated caspase-independent cell death pathways.  
 
4. Discussion 
The results here presented using brain ECs treated with Aβ1–40 highlight the role of the ER stress-mediated 
apoptotic cell death pathway in vascular alterations that occur in AD brain. This hypothesis is supported by 
our findings demonstrating that Aβ1–40: i) compromises EC survival; ii) induces ER stress, increasing the 
levels of several mediators of UPR signalling pathways; iii) induces loss of ER Ca2+ homeostasis 
concomitantly increasing cytosolic Ca2+ levels; iv) upregulates the ER stress-associated pro-apoptotic 
transcription factor CHOP/GADD153; v) activates a mitochondria-independent cell death pathway associated 
with activation of the ER resident caspase-12; vi) triggers the early translocation of Bax to mitochondria 
leading to cytochrome c release and subsequent caspase-9 and caspase-3 activation (caspase-dependent 
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pathway) and also to the release of AIF from mitochondria and translocation to the nucleus (caspase-
independent pathway).  
AD patients frequently have deposits of Aβ in cerebral arteries, veins and capillaries possibly due to reduced 
trans-endothelial clearance of Aβ [7]. Previous studies demonstrate that Aβ could deregulate ECs causing 
morphological and functional alterations and inducing apoptosis [9, 13, 14]. However, the mechanisms 
responsible for Aβ-induced apoptotic cell death in these cells have not been fully elucidated. In this study, we 
demonstrated that Aβ1-40 affects the survival of brain ECs in a dose- and time-dependent manner using the 
RBE4 cell line. Furthermore, we were able to show that toxic concentrations of Aβ1-40 increase the 
percentage of apoptotic cells, in the absence of significant alterations in the number of necrotic cells. 
We previously demonstrated that Aβ induces neuronal apoptosis through ER stress activation [37, 38]. In 
ECs, ER stress and consequent activation of UPR has been reported to be triggered by several stimuli [45-
47]. Some metabolic diseases associated with vascular abnormalities, such as obesity and type 2 diabetes, 
are risk factors for AD [48] and are known to affect Aβ production [49]. Moreover, several studies indicate that 
ER stress contributes to the pathogenesis of obesity and diabetes [50]. Aβ1-40 inhibits human brain vascular 
ECs proliferation [14] and induces apoptosis [51]. However, the role of Aβ in the ER stress response in brain 
ECs is unknown. To demonstrate the effect of Aβ in the ER stress response in these cells, the levels of 
ATF4, spliced XBP-1, and cleaved ATF6α, which occur downstream of the activation of the ER stress 
sensors PERK, IRE1, and ATF6, respectively, and also of GRP78, a molecular chaperone, and unspliced 
XBP-1 that are an ER stress target genes [17], were analyzed after Aβ1-40 treatment. A significant increase in 
the levels of these ER stress markers was detected in Aβ1-40-treated RBE4 cells clearly indicating that Aβ1-40 
activates the ER stress-associated UPR signalling pathways in brain ECs. 
One of the functions of vascular ECs from the BBB is to remove Aβ from the brain. The accumulation of 
proteins inside the ER, which activates the UPR and consequently inhibits protein translation, decreases the 
traffic of proteins in the secretory pathway. Consequently, the levels of Aβ transporters at the plasma 
membrane can decrease leading to Aβ accumulation in brain. Accordingly, the ratio between Aβ efflux and 
influx in AD patients' brain is decreased compared to healthy subjects showing that Aβ clearance from the 
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brain is compromised in the disease [52]. Moreover, ER stress was demonstrated to increase Aβ production 
and subsequent accumulation [53]. The accumulation of misfolded/unfolded proteins in the ER is 
accompanied by alterations in ER Ca2+ homeostasis. Furthermore, familial AD mutations in PSs, components 
of the γ-secretase complex involved in Aβ production [54], have been linked to the perturbation of Ca2+ 
homeostasis [55-57]. For instance, PS1 holoprotein seems to form a complex with the SERCA channel and 
contribute to the regulation of ER Ca2+ levels [58]. Consequently, alterations in PSs that impair the formation 
of ER Ca2+ leak channels causes neurodegeneration independent of γ-secretase activity [56]. It was also 
found that some sporadic AD brains preferentially express an alternative splicing form of PS2 (lacking exon 
5) compared with those of age-matched controls [59]. When ER Ca2+ levels decrease, the Ca2+-dependent 
chaperones cannot function properly and misfolded/unfolded proteins accumulate within the ER activating the 
UPR [60]. Alteration of intracellular Ca2+ concentration, reactive oxygen species, blocked ER-to-Golgi 
transport, inhibition of protein degradation, decrease in ATP levels and other insults may also cause ER 
stress and release of Ca2+ from the ER lumen into the cytoplasm [61]. Previously, we demonstrated in 
primary cultured neurons that Aβ induces the release of Ca2+ from the ER leading to cytosolic Ca2+ rise and 
activation of apoptotic cell death [38]. Here, ER Ca2+ content was shown to be decreased in brain ECs, and 
to be followed by a significant increase in cytosolic Ca2+ levels upon Aβ1-40 exposure. These findings are in 
accordance with the results obtained by Kito and co-workers who demonstrated, in another brain EC line, that 
ER stress increases intracellular Ca2+ levels [47]. 
The release of Ca2+ from ER and consequent increase in cytosolic Ca2+ levels can activate pathways that 
culminate in apoptosis [62-64]. Deregulation of the BBB is a primary event in AD, which occurs before 
neuronal loss that underlies the prominent brain atrophy found in the brain of patients [5, 65]. The activation 
of apoptosis in the brain of AD patients is a controversial issue, but several studies found activation of 
caspase-3 in AD patients [66] . Additionally, recent studies also show apoptosis in vascular cells in AD 
patients [67] . Furthermore, several in vitro studies found that Aβ induces apoptosis in neurons, ECs, 
pericytes, and other brain cells [38, 68, 69] . Moreover, cerebrovascular accumulation of Aβ in mice was 
shown to induce apoptotic cell death in ECs [8]. In our previous studies, we demonstrated the involvement of 
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ER Ca2+ release induced by different Aβ peptides in mitochondria-mediated apoptosis in cortical neurons and 
AD cybrids [28, 38, 70]. Thapsigargin-mediated perturbation in Ca2+ homeostasis was shown to led to 
apoptosis in a cross-talk between the death receptor and mitochondrial pathways [71]. Ca2+ channels 
associated with the ER ryanodine receptor (RyR) are involved in Ca2+ homeostasis and control ER-to-
mitochondria Ca2+ transfer [72]. The prevention of Aβ1-40-induced decrease in mit promoted by dantrolene, 
an RyR inhibitor, demonstrates the involvement of Ca2+ released from the ER in mitochondrial membrane 
depolarization and consequent induction of mitochondria-dependent apoptosis in ECs. After prolonged or 
intense activation of UPR and perturbation of ER Ca2+ homeostasis, the pro-apoptotic transcription factor 
CHOP/GADD153 can be upregulated [24, 73]. In turn, CHOP/GADD153 upregulates the pro-apoptotic BH3-
only protein Bim [74], inhibits the transcription of the anti-apoptotic Bcl-2 protein and induces the translocation 
of Bax to mitochondria and the subsequent cytochrome c release and activation of caspase-9 and -3, finally 
leading to apoptosis [26, 75]. Therefore, the reduction in ER Ca2+content, as well as the activation of ER 
stress and the consequent augment of CHOP/GADD153 protein levels can induce mitochondria-mediated 
apoptosis thus explaining the decrease in cells viability and the increase in the number of apoptotic cells 
observed after Aβ1-40 treatment. To confirm this hypothesis, Bcl-2, Bax, and cytochrome c protein levels were 
analyzed in mitochondrial and cytosolic fractions of RBE4 cells and mit was measured. The Bax/Bcl-2 
ratio, which could be used to predict mitochondria-mediated apoptosis, increased in mitochondria, especially 
due to an increase of Bax levels, and decreased in cytosol in Aβ1-40-treated cells, suggesting that Aβ1-40 
induces the translocation of Bax to mitochondria. Bax can form pores in the mitochondrial membrane 
permitting the release of ions and consequently decrease in mit. Moreover, cytochrome c can be released 
from mitochondria and induce apoptosis. Accordingly, cytochrome c levels were significantly decreased in 
mitochondria and increased in cytosol after incubation with Aβ1-40 and the downstream caspase-9 was shown 
to be activated under these conditions. Furthermore, the activity of caspase-3 increased upon Aβ1-40 
treatment leading to the cleavage of PARP1, a DNA repair enzyme [76]. These alterations in pro-apoptotic 
mediators follow changes in ER and cytosolic Ca2+ homeostasis, ER stress markers and precede the 
decrease in cell viability and the increase in the number of apoptotic cells suggesting that Aβ1-40 activates a 
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mitochondrial-mediated apoptotic cell death pathway triggered by ER stress in brain ECs. During prolonged 
ER stress, the ER membrane resident caspase-12 can be activated subsequently initiating a mitochondria-
independent caspase cascade that finally leads to apoptosis [17]. Caspase-12 is activated under ER stress 
conditions, including disruption of ER Ca2+ homeostasis and excessive accumulation of proteins in ER lumen, 
but not by membrane- or mitochondrial-targeted apoptotic signals [77]. Additionally, the increase in cytosolic 
Ca2+ levels resulting from ER stress activates calpains that in turn activate the murine caspase-12 [78, 79]. 
However, UPR induction in the absence of caspase-12 activation has also been previously found in ECs [80]. 
In this work, the protein levels of caspase-12 were significantly increased in Aβ1-40-treated ECs together with 
an increase in caspase-12-like activity, which reached maximal activation at 12 hr of incubation. Caspase-12 
can activate caspase-9 (in an Apaf-1 and cytochrome c independent manner) that in turn activates the 
apoptosis effector caspase-3 [78]. Aβ1-40 activated both caspase-3 and -9 after 6 and 12hr incubation. These 
results support that Aβ-induced ER stress triggers apoptotic cell death in brain ECs also by mitochondria-
independent cell death pathways.  
In this study, caspase-12 activation and Bax translocation into mitochondria and subsequent cytochrome c 
release and caspases-9 and -3 activation have a maximum increase 12 hr after Aβ1-40 treatment but 
decreased at 24 hr. However, cell viability continues to decrease and the number of apoptotic cells continues 
to increase at 24 hr of incubation. These findings suggest that alternative mechanisms must be implicated in 
the compromise in cell survival and significant apoptotic cell death at later stages (24 hr). It is know that Aβ in 
brain patients with AD excessively increase PARP1 activity, also present in mitochondria, leading to the 
accumulation of poly(ADP-ribose) that in turn induces the release of AIF from mitochondria and consequent 
translocation to the nucleus [81]. Furthermore, activation of calpains after increase in cytosolic Ca2+, 
alterations in mit and the formation of pores in mitochondrial membrane by Bax or other pro-apoptotic Bcl-
2 family member could also promote AIF release from mitochondria and its nuclear translocation [82, 83]. In 
the nucleus, AIF leads to chromatin condensation and DNA fragmentation and triggers caspases-
independent apoptosis [84]. Accordingly, treatment of RBE4 cells with Aβ1-40 for 24 hr increased the levels of 
AIF in the nucleus. The AIF-mediated apoptosis can partially explain the differences in the percentage of cell 
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death measured by the TUNEL assay versus Hoechst 33342/PI since the morphology of the nucleus during 
apoptosis induced by AIF is not easily discriminated from that of controls [84]. 
The ER is a key regulator of several cellular processes and therefore its dysfunction might compromise 
seriously cell survival [85]. The activation of the UPR is a protective mechanism to counteract ER stress and 
re-establish homeostasis. However, when ER stress is prolonged or too severe, apoptotic cell death is 
induced, which can occur through different mechanisms (CHOP upregulation, caspase-12 activation, JNK 
activation,…)[86]. Since the ER sensors IRE1, ATF6 and PERK and downstream UPR signalling pathways 
are implicated in both cell survival and death, ER stress inhibitors can prevent ER stress-induced cell death 
but can also interfere with cell survival pathways and impair the numerous ER-dependent cellular functions. 
For that reason, we do not expect that strategies to prevent UPR activation can revert the toxic Aβ effects, 
since loss of protective pathways will turn cells more sensitive to stress. Accordingly, we tested several ER 
stress inhibitors such as TUDCA (tauroursodeoxycholic acid), PBA (4-phenylbutyric acid), VPA (valproic acid 
sodium), alone or in combination, in ECs treated with two well known ER stress inducers, thapsigargin and 
brefeldin A, or with Aβ and we were not succeeded in protecting cells from ER stress-induced apoptosis (data 
not shown). In addition, we can not exclude the activation of ER-independent cell death pathways by Aβ, 
which are not rescued by ER stress inhibitors. Finally, the increases in the levels of CHOP and caspase-12, 
as well as in caspase-12 activity in Aβ-treated ECs, support that this peptide induces an ER stress-mediated 
apoptotic cell death pathway. 
 
5. Conclusion 
In conclusion, our findings support that vascular alterations in AD arise from the deleterious effects of Aβ1-40 
on brain ECs that activate cell death pathways through the perturbation of ER Ca2+ homeostasis and 
induction of ER stress (Fig. 8). These evidences could contribute to the development of novel therapeutic 
strategies targeting the ER to prevent or delay the progression of AD. 
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Titles and legends to figures 
Figure 1. Aβ1-40 decreases brain endothelial cell survival activating apoptotic cell death. (A) RBE4 cells 
treated with 2.5 μM Aβ1-40 for 3 hr were stained with ThS to detect β-sheet Aβ species and observed with 
400x amplification in a confocal microscope. (B) Additionally, cells were treated with 0.1 or 2.5 μM Aβ1-40 for 
3, 6, 12, or 24 hr and cell viability was evaluated by the MTT assay. Data correspond to the percentage of the 
absorbance determined under control conditions (untreated cells). (C) Moreover, RBE4 cells were incubated 
for 6 or 24 hr with 2.5 μM Aβ1-40 and the release of LDH was measured to monitor necrosis-associated loss of 
plasma membrane integrity. The results correspond to the percentage of LDH released to the extracellular 
medium and are presented relative to control. (D-G) Furthermore, cells were incubated with 2.5 μM Aβ1-40 for 
24 hr and the number of apoptotic and necrotic cells was measured with Hoechst 33342/PI staining (D and E) 
or by the TUNEL assay (F and G). In (D) are represented the Hoechst 33342, PI and merged images and in 
(F) are represented the phase contrast, the fluorescence (green) and the merged images of TUNEL-stained 
cells visualized with 400x amplification. A minimum of 150 cells were scored for each coverslip and the 
number of dead cells, presented as the percentage of total number of cells (E and G), was quantified. Data 
represent the means ± SEM of at least three independent experiments performed in duplicate. ***p<0.001 
significantly different from control. 
 
Figure 2. Aβ1-40 induces ER stress in brain endothelial cells. RBE4 cells were treated with 2.5 μM Aβ1-40 
peptide for 3, 6, 12, or 24 hr and then ATF4 (A and B), unspliced XBP-1 (A and C), spliced XBP1 (A and D), 
cleaved ATF6α (A and E), and GRP78 (A and F) protein levels were quantified by WB. Proteins (15 μg) from 
cell lysates were separated by SDS-PAGE and immunoblotted with specific antibodies. An anti-α-tubulin 
antibody was applied as a protein loading control and used to normalize ER stress protein levels. The results 
were calculated relatively to control values and represent the means ± SEM of at least eight independent 
experiments. (G and H) Additionally, cells cultured in glass coverslips were incubated with 2.5 μM Aβ1-40 for 
6hr and the nuclear localization of ATF6α was analyzed by immunocytochemistry using an antibody against 
ATF6α and Hoechst 33342 to label nuclei. (G) Fluorescence images of control and treated cells were 
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visualized with 630x amplification in a confocal microscope. (H) The ATF6α staining in the nucleus of a 
minimum of 100 cells for each coverslip was measured using the WCIF ImageJ program. Results were 
calculated as the means ± SEM of at least three independent experiments performed in duplicate and were 
normalized to control values. *p<0.05, **p<0.01, and ***p<0.001 significantly different from control. 
 
Figure 3. ER and cytosolic Ca2+ content is affected in Aβ1-40-treated brain endothelial cells. (A) The 
fluorescence ratio at 340/380 nm of the Ca2+-sensitive probe Fura-2/AM was monitored in the absence of 
external Ca2+ in controls and in cells treated with Aβ1-40 for 3 or 24 hr. After establishment of a basal 
fluorescence signal, 2.5 μM thapsigargin was added to deplete ER Ca2+ content. A representative experiment 
is presented in. (B) The peak amplitude of Fura-2 fluorescence was used to evaluate ER Ca2+ content. (C) 
Additionally, cytosolic Ca2+ levels were analyzed using the Ca2+ dye Indo-1/AM after treatment of RBE4 cells 
with 2.5 μM Aβ1-40 for 3, 6, 12, or 24 hr. Data were normalized to control and represent the means ± SEM of 
at least three independent experiments performed in duplicate. **p<0.01 and ***p<0.001 significantly different 
from untreated cells. 
 
Figure 4. CHOP protein levels are increased by Aβ1-40 treatment in brain endothelial cells. RBE4 cells were 
treated with 2.5 μM Aβ1-40 for 3, 6, 12, or 24 hr and then CHOP protein levels were quantified by WB. Protein 
(15 μg) obtained from cell lysates was separated by SDS-PAGE and immunoblotted with the respective 
antibody. An anti-α-tubulin antibody was used as a protein loading control and used to normalize CHOP 
protein levels (A and B). The results were normalized to control and represent the means ± SEM of at least 
eight independent experiments. **p<0.01 significantly different from control. 
 
Figure 5. The mitochondria-mediated apoptotic cell death pathway is activated by Aβ1-40 in brain endothelial 
cells. After treatment of RBE4 cells with 2.5 μM Aβ1-40 for 3, 6, 12, or 24 hr, mitochondrial and cytosolic 
extracts were prepared and proteins (30 μg) were separated by SDS-PAGE and immunoblotted with anti-Bcl-
2, anti-Bax (A, B and C), and anti-cytochrome c (A, D and E) antibodies. Anti-TBP and anti-GAPDH 
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antibodies were applied as protein loading control for nuclear and cytosolic fractions respectively. Bax/Bcl-2 
ratio in the mitochondria (B) and in the cytosol (C) was calculated. The ratio between mitochondrial and total 
(cytosolic plus mitochondrial) cytochrome c levels (D) and the ratio between cytosolic and total cytochrome c 
levels (E) were also calculated. Additionally, the mit was measured upon Aβ1-40 (F) and dantolene (G) 
treatment of RBE4 cells using the fluorescent probe TMRM. The results were normalized to control and 
represent the means ± SEM of at least five independent experiments. *p<0.05, **p<0.01, and ***p<0.001 
significantly different from control and ### p<0.001 significantly different fom Aβ1-40 treated ECs. 
 
Figure 6. Aβ1-40 treatment activates caspases-3, -9, and -12 in brain endothelial cells and induces PARP1 
cleavage. (A-C) RBE4 cells were treated with 2.5 μM Aβ1-40 for 3, 6, 12, or 24 hr and then pro-caspase-12 
and caspase-12 protein levels were quantified by WB. Proteins (15 μg) obtained from cell lysates were 
separated by SDS-PAGE and immunoblotted with a specific antibody and an anti-GAPDH antibody applied 
as a protein loading control. The ratio between pro-caspase-12 (B) or caspase-12 (C) and GADPH was 
calculated. The presented results were normalized to control values and represent the means ± SEM of at 
least five independent experiments performed in duplicate. In addition, caspase-12 (D), caspase-9 (E), and 
caspase-3 (F)-like activities were determined in cell lysates using the colorimetric substrates Ac-LEVD-pNA, 
Ac-LEHD-pNA, and Ac-DEVD-pNA, respectively. The presented results were normalized to control and 
represent the means ± SEM of at least three independent experiments performed in duplicate. (G) Moreover, 
RBE4 cells cultured in glass coverslips were incubated with 2.5 μM Aβ1-40 for 12 or 24 hr and the cleavage of 
PARP1 was analyzed by immunocytochemistry using an antibody against the large fragment of PARP1 
resulting from caspase cleavage at Asp214 and Hoechst 33342 to label nuclei. Fluorescence images of 
control and treated cells were visualized with 400x amplification. *p<0.05 and ***p<0.001 significantly 
different from untreated cells. 
 
Figure 7. Aβ1-40 induces the translocation of AIF to the nucleus in brain endothelial cells. After treatment of 
RBE4 cells with 2.5 μM Aβ1-40 for 3, 6, 12, or 24 hr, cytosolic (A), mitochondrial (A and B) and nuclear (A and 
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C) extracts were prepared and proteins (30 μg) were separated by SDS-PAGE and immunoblotted with an 
anti-AIF antibody. Anti-GAPDH (for cytosolic fractions), anti-Tom20 (for mitochondrial fractions) and TBP (for 
nuclear fractions) antibodies were applied as protein loading control and used to normalize AIF protein levels. 
The results were normalized to control and represent the means ± SEM of at least six independent 
experiments. **p<0.01 and ***p<0.001 significantly different from control. 
 
Figure 8. Aβ triggers apoptosis in brain endothelial cells through activation of stress responses and 
deregulation of Ca2+ homeostasis in the ER. Aβ induces the release of Ca2+ and accumulation of unfolded 
proteins in the endoplasmic reticulum (ER) leading to the activation of the ER stress-mediated UPR 
(activation of ATF6, IRE1, and PERK signalling pathways). Consequently, the transcription factors cleaved 
ATF6, spliced XBP-1 (sXBP-1), and ATF4 are translocated to the nucleus and induce the transcription of 
several genes such as the pro-apoptotic CHOP that increases the Bax/Bcl-2 ratio in mitochondria leading to 
the release of cytochrome c and AIF. Cytochrome c binds to Apaf-1 and activates caspase-9, which in turn 
activates the apoptosis effector caspase-3. On the other hand, severe ER stress is associated with massive 
release of Ca2+ from ER and activates caspase-12 that activates caspase-9 independently of Apaf-1. After 
translocation to the nucleus, AIF promotes chromatin condensation and DNA fragmentation resulting in 
apoptosis. PARP1 can repair DNA damage, however it is cleaved by caspases such as caspase-3 during 
apoptosis. Moreover, the Ca2+ released from ER is transferred to mitochondria, causing Ca2+ overload and 
decrease of mitochondrial membrane potential (Δψm), leading to the release of apoptotic factors. 
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Highlights 
 
The Aβ1–40 peptide in rat brain endothelial cell line (RBE4) induces:  
i) ER stress, increasing the levels of several mediators of UPR signalling pathways 
ii) loss of ER Ca2+ homeostasis concomitantly increasing cytosolic Ca2+ levels 
iii) upregulates the ER stress-associated pro-apoptotic transcription factor CHOP 
iv) activation of a mitochondria-independent cell death pathway through caspase-12 
v) caspase-dependent and independent apoptosis though cytochrome c and AIF 
 
